Last updated: 2026-02-08 02:56:19 ET
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug
Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was "illegal"
The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
Treasury Secretary Scott Bessent used his House testimony Wednesday (Feb. 4) to spotlight an urgency for new bank formation. More than half of community
Treasury Secretary Scott Bessent used his House testimony Wednesday (Feb. 4) to spotlight an urgency for new bank formation. More than half of community
The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its direct-to-consumer sales strategy.
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a de...
Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
